Shanghai - Delayed Quote CNY

Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS)

29.12
-0.88
(-2.93%)
At close: 3:00:01 PM GMT+8
Loading Chart for 603882.SS
  • Previous Close 30.00
  • Open 29.78
  • Bid 29.11 x --
  • Ask 29.12 x --
  • Day's Range 28.91 - 29.82
  • 52 Week Range 24.35 - 42.00
  • Volume 6,858,329
  • Avg. Volume 10,712,281
  • Market Cap (intraday) 13.49B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.84
  • Earnings Date --
  • Forward Dividend & Yield 1.76 (5.87%)
  • Ex-Dividend Date Feb 21, 2025
  • 1y Target Est --

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

www.kingmed.com.cn

10,413

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 603882.SS

View More

Performance Overview: 603882.SS

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

603882.SS
8.14%
SSE Composite Index (000001.SS)
0.85%

1-Year Return

603882.SS
20.09%
SSE Composite Index (000001.SS)
7.02%

3-Year Return

603882.SS
61.43%
SSE Composite Index (000001.SS)
7.42%

5-Year Return

603882.SS
52.37%
SSE Composite Index (000001.SS)
20.13%

Compare To: 603882.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603882.SS

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    13.90B

  • Enterprise Value

    12.66B

  • Trailing P/E

    --

  • Forward P/E

    33.00

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.04

  • Price/Book (mrq)

    2.02

  • Enterprise Value/Revenue

    1.86

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.73%

  • Return on Assets (ttm)

    -1.14%

  • Return on Equity (ttm)

    -5.49%

  • Revenue (ttm)

    6.81B

  • Net Income Avi to Common (ttm)

    -390.39M

  • Diluted EPS (ttm)

    -0.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.99B

  • Total Debt/Equity (mrq)

    10.66%

  • Levered Free Cash Flow (ttm)

    733.11M

Research Analysis: 603882.SS

View More

Company Insights: 603882.SS

Research Reports: 603882.SS

View More

People Also Watch